Abstract:Objective To explore the efficacy and safety of endoscopic ligation in treatment of gastric submucosal tumors (diameter ≤ 1 cm).Methods Clinical data of 177 patients with gastric submucosal tumors who received endoscopic therapy from October 2020 to July 2022 were retrospectively analyzed. Patients were divided into endoscopic submucosal dissection (ESD) group (n = 142) and endoscopic ligation group (n = 35) according to different endoscopic treatment methods, and the operation time, intraoperative complications, postoperative hospital stay, surgical cost, complete lesion resection, postoperative complications and pathology of the two groups were compared.Results The operative time of the ESD group was (33.23 ± 8.55) min, which was significantly longer than that of the endoscopic ligation group (24.85 ± 5.96) min. The intraoperative bleeding was ERB-c1 and no ERB-c2 of the ESD group, which was better than that of the endoscopic ligation group, and the operative cost was (24 615.08 ± 5 678.32) yuan, significantly more than that of the endoscopic ligation group (21 319.26 ± 7 235.95) yuan, the differences were statistically significant (P < 0.05). There was no significant difference in the intraoperative perforation rate, postoperative hospitalization time and postoperative follow-up time between the two groups (P > 0.05). No surgical transfer, serious infection, delayed hemorrhage and perioperative death occurred in both groups, and no tumor recurrence, metastasis and death were found.Conclusion Endoscopic ligation has the advantages of relatively safe, efficient, less blood loss and low cost, but it has the risk of bleeding which is difficult to predict. Therefore, it is particularly important to select appropriate treatment after adequate evaluation.